Product Information
MCL 0020 is a small molecule drug that has been shown to alleviate the cognitive deficits in a transgenic mouse model of Alzheimer's disease. MCL 0020 binds to the element binding protein and increases the levels of melanocortin, which enhances long-term potentiation and synaptic plasticity. MCL 0020 also modulates synaptic dysfunction and reverses synaptic loss in a transgenic mouse model of Alzheimer's disease. The potential for MCL 0020 as an Alzheimer's treatment is highlighted by its ability to significantly improve cognitive function in mice with an app/ps1 transgenic, which mimics early-stage Alzheimer's pathology.
Chemical properties
Technical inquiry about: 3D-AUA49826 MCL 0020
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
